Diprivan Injection, Emulsion
Product Images NDC 63323-269

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Diprivan (NDC 63323-269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dipri-fig-01.jpg (Dipri Fig 01)

Dipri-fig-01.jpg (Dipri Fig 01)
A line graph depicting plasma propofol concentration (µg/mL) over time (minutes) after the end of infusion. It compares recovery profiles following 1-hour, 10-hour, and 10-day infusions, with a marked target plasma concentration and an indicated awakening time point.*
FDA Label Image

Dipri-label-01.jpg (Dipri Label 01)

Dipri-label-01.jpg (Dipri Label 01)
Label for Diprivan (Propofol) injectable emulsion, USP, 100 mg per 10 mL (10 mg per mL) in a 10 mL single-dose vial by Fresenius Kabi USA, LLC. The label includes storage instructions, usage warnings, and a barcode, indicating intravenous administration and advising to shake well before use.*
FDA Label Image

Dipri-label-02.jpg (Dipri Label 02)

Dipri-label-02.jpg (Dipri Label 02)
Packaging label for Diprivan (Propofol) injectable emulsion, USP, 100 mg per 10 mL (10 mg per mL) for intravenous administration. The carton indicates ten 10 mL single-dose vials and instructs to shake well before using. Labeler is Fresenius Kabi USA, LLC, with storage and use instructions, including a caution to discard within 12 hours of opening. The label includes NDC 63323-269-16 and is made in Austria.*
FDA Label Image

Dipri-label-03.jpg (Dipri Label 03)

Dipri-label-03.jpg (Dipri Label 03)
Label for Diprivan (Propofol) injectable emulsion, USP, 10 mg/mL strength with a total of 200 mg per 20 mL in a single-dose vial. The label includes storage instructions (store between 4° to 25°C), manufacturer Fresenius Kabi USA, LLC, lot and expiration placeholders, and cautions regarding aseptic technique and microbial growth inhibition by EDTA. It indicates the product is for intravenous administration and advises shaking well before use.*
FDA Label Image

Dipri-label-04.jpg (Dipri Label 04)

Dipri-label-04.jpg (Dipri Label 04)
Label for Diprivan (Propofol) injectable emulsion USP, 200 mg per 20 mL (10 mg per mL), by Fresenius Kabi USA, LLC. The label states it is for intravenous administration, single-dose 20 mL vials. It includes instructions to shake well before use, warnings about aseptic technique, and notes that the product contains EDTA to inhibit microbial growth. The label also mentions the product is sterile and nonpyrogenic, with storage instructions and manufacturer details.*
FDA Label Image

Dipri-label-05.jpg (Dipri Label 05)

Dipri-label-05.jpg (Dipri Label 05)
Diprivan (Propofol) injection emulsion label showing 500 mg per 50 mL (10 mg per mL) strength for intravenous administration. The single-dose vial is 50 mL, manufactured by Fresenius Kabi USA, LLC. Label includes storage instructions, aseptic technique warnings, and ingredient details.*
FDA Label Image

Dipri-label-06.jpg (Dipri Label 06)

Dipri-label-06.jpg (Dipri Label 06)
Packaging label for Diprivan (Propofol) injectable emulsion USP, 500 mg per 50 mL (10 mg per mL), for intravenous administration. The label indicates twenty 50 mL single-dose vials and includes instructions to shake well before use. Labeler is Fresenius Kabi USA, LLC, featuring regulatory and handling warnings on the carton.*
FDA Label Image

Dipri-label-07.jpg (Dipri Label 07)

Dipri-label-07.jpg (Dipri Label 07)
Label for Diprivan (Propofol) Injection Emulsion USP, 10 mg/mL (1000 mg per 100 mL) single-dose vial. The label indicates intravenous administration and includes instructions like 'Shake well before using.' Manufactured by Fresenius Kabi USA, LLC, it states sterility, nonpyrogenicity, and contains warnings about microbial growth and discard times after opening.*
FDA Label Image

Dipri-label-08.jpg (Dipri Label 08)

Dipri-label-08.jpg (Dipri Label 08)
Diprivan (Propofol) injectable emulsion USP 1000 mg per 100 mL (10 mg/mL) carton label for intravenous administration. The label indicates single-dose vials, ten 100 mL vials per package, and includes instructions to shake well before use. It is labeled for RX only and manufactured by Fresenius Kabi USA, LLC under the Novaplus brand.*
FDA Label Image

Dipri-logo-01.jpg (Dipri Logo 01)

FDA Label Image

Dipri-struc-01.jpg (Dipri Struc 01)

Dipri-struc-01.jpg (Dipri Struc 01)
Chemical structure of propofol, showing a benzene ring with two isopropyl groups and one hydroxyl group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.